Beijing Strong Biotechnologies, Inc. (ASX: 300406) has announced that it has received a Medical Device Registration Certificate from the Beijing Medical Products Administration for its Thyroxine Uptake Assay Kit, which utilizes magnetic particle chemiluminescence immunoassay technology.
This kit is designed for the in vitro quantitative determination of thyroxine uptake (T-Uptake) in human serum or plasma.
The acquisition of this registration certificate enriches the company's product portfolio within the specialized field of in vitro diagnostic chemiluminescence.
This development is expected to enhance the company's core competitiveness and market expansion capabilities, positively impacting its future business operations.